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occurred in the IMI group but not in the AMI group. Improvements in LVEF and MR were
similar in both groups. CONCLUSION: Infarct location determines the extent of reverse
LV remodeling in HF pts treated with CRT independent of baseline LV volume and func-
tion. 
* p<0.05 AMI vs IMI
† p<0.05 within group changes, baseline to 6-months
8:45 a.m.
872-2 Upgrade From Standard Right Sided Pacing to Cardiac 
Resynchronization Therapy Shows Clinical Benefit as in 
De Novo Implantation
Salpy V. Pamboukian, Imran Nisar, Sheetal Patel, Liping Gu, Mary McLeod, Stephanie 
Dunlap, Richard Trohman, Maria Rosa Costanzo, Alain Heroux, University of Alabama at 
Birmingham, Birmingham, AL, Rush Presbyterian St. Luke's Medical Center, Chicago, IL
Background: Cardiac resynchronization therapy (CRT) produces clinical benefit in heart
failure (HF) patients (pts) with intraventricular conduction delay. Previous studies
excluded pts who already had a pacing device. In this study, pts with denovo (DN) CRT
were compared to those undergoing upgrade (UP) to CRT from standard pacing.
Methods: Data from the Rush Heart Failure Database was collected including demo-
graphics, cause of HF, NYHA class, echo data (left ventricular ejection fraction LVEF, LV
end diastolic dimension EDD, mitral regurgitation MR, tricuspid regurgitation TR), ECG
intervals, drugs, hospitalizations (hosp), length of stay (LOS), procedure complications
and mortality. Statistics were performed using t test, Fisher's exact test, Wilcoxon test.
Results: Twenty eight pts had DN implant (19 male, 13 ischemic, LVEF 20%, LVEDD
72mm), 21 pts had UP (15 male, 13 ischemic, LVEF 24%, LVEDD 73mm). Age was 61+9
yrs in DN versus (vs) 67+10 in UP (p<0.01). PR interval was 188+34ms in DN vs
156+57ms in UP. QRS duration was 152+21ms in DN vs 181+35ms in UP (p<0.01). In
the DN, LVEDD decreased by 4+2mm after CRT (p=0.04). In the UP, MR was less after
CRT(p=0.02). Both groups had improved NYHA class immediately after CRT (p=0.02). In
DN group this was still seen at 6 and 12 months (P<0.01). No difference was seen in the
number of hosp in the groups 6 months before and after CRT. There was a trend to
shorter LOS in the in the DN pts after CRT, -5+ 2.5days(p=0.07). Dose of metoprolol suc-
cinate was 62+17mg at baseline in DN pts but increased by 53+19mg after CRT(p=0.01).
Carvedilol dose was unchanged. No difference in beta blocker dose after CRT was seen
in the UP pts. There were no differences in CRT related complications. There were 3
deaths in UP, 4 in DN group.
Conclusion: HF pts with standard pacing benefit from upgrade to CRT with improved
NYHA class and decreased MR, without increased procedure related complications.
CRT allows for uptitration of beta blockers in DN implants.
9:00 a.m.
872-3 Reverse Remodeling After Cardiac Resynchronization 
Therapy and Analysis of Effect in Heart Failure Patients 
With or Without an Indication for Implantable 
Cardioverter Defibrillator
Martin G. St. John Sutton, Ted Plappert, Kathryn E. Hilpisch, Edward Chinchoy, 
University of Pennsylvania Medical Center, Philadelphia, PA, Medtronic, Inc, Minneapolis, 
MN
Evidence of reverse remodeling with CRT in moderate to severe heart failure (HF)
patients (pts) with ventricular dysynchrony has been reported in several trials. An analy-
sis was done to compare the results of a CRT versus a CRT+ICD trial. METHODS: We
compared the magnitude of remodeling of two separate CRT trials differentiated by pts
with and without an indication for an ICD. The MIRACLE and MIRACLE ICD trials
enrolled HF pts (NYHA III/IV, QRS>130ms, LVEDD >55mm and EF<35%) and implanted
them with an InSync (atrial synchronous biventricular pacer) or an InSync ICD system,
respectively. In all pts AV delay was echocardiographically optimized by maximizing left
transmitral filling without truncating the A wave. Patients were randomized to no pacing
(control) or to treatment (CRT or CRT+ICD). Peak VO2 consumption (pVO2), 6-minute
hall walk distance (6’HW) and Quality of life (QoL) were compared. Doppler echocardio-
grams were recorded in pts at baseline and 6 months, and analyzed by a core laboratory.
LV end diastolic volume (LVEDV), LV end systolic volume (LVESV), LV ejection fraction
(LVEF), Deceleration time (DT), and mitral regurgitation color flow jet area (MR) were
obtained. Only treatment patients with paired baseline and 6 mos data were used.
RESULTS: See table. CONCLUSIONS: The magnitude of clinical improvements and
reverse remodeling quantified using echocardiographic indices was similarly evident in
both trials regardless of indication or placement of an ICD. *p<0.05 between baseline and
6 months. 
9:15 a.m.
872-4 Benefit of Biventricular Pacing in Subsets of Patients 
With Heart Failure
Kenneth Ng, Navin Kedia, Randall Starling, Bruce Wilkoff, Pat Tchou, David Martin, 
Richard Grimm, Cleveland Clinic Foundation, Cleveland, OH
Background
Extending the current indications for cardiac resynchronization therapy (CRT) to patients
with NYHA Class II symptoms, RV pacing or QRS < 150ms has been proposed however
no data has yet been reported to support this recommendation.
Methods
One-hundred and forty-four consecutive heart failure patients underwent CRT from Janu-
ary 1999 to January 2002. Clinical parameters of NYHA Class, QRS duration, LVEF, LV
end-systolic (LVESD) and end-diastolic (LVEDD) dimensions were monitored at baseline
and end of follow-up with a mean of 330 ± 220 days.
Results
At baseline, 20 patients, 88 patients and 36 patients were in NYHA Class II, Class III and
Class IV respectively, 34 patients with right ventricle pacing, and 29 patients with a QRS
duration <150ms. After CRT, the patients who were in NYHA Class II had significant
improvement in LVEF and LV dimensions. Patients with RV pacing had significant
improvement in NYHA Class, QRS duration, LVEF and LV dimensions. The patients with
QRS duration < 150ms had significant improvement in NYHA class and a significant
increase in the QRS duration.(Table I)
Conclusion
Non-conventional candidates for CRT may derive significant structural and functional
benefit with CRT and should be analyzed in future clinical trials. 
* denotes difference is significant, p<0.05
9:30 a.m.
872-5 Incidence of Diastolic Dyssynchrony in Dilated 
Cardiomyopathy and Effects of Biventricular Pacing
Christophe Jego, Iris Schuster, Christine Medail, Jean Lefevre, Frederic Franceschi, 
Jean-Marie Vailloud, Ange Ferracci, Jean-Claude DeHaro, Pierre Djiane, Gilbert H. 
Habib, La Timone Hospital, Marseille, France
Background. Resynchronization is an accepted treatment of dilated cardiomyopathy
(DCM). Its benefit has been related to the correction of systolic (S) dyssynchrony (DYS)
either interventricular (Inter) or intraventricular (Intra). However, little is known about dias-
tolic (D) DYS and the effects of biV pacing on it
Objectives: 
1 - to compare the respective occurrence of D and S DYS in pts with DCM and LBBB.
2 – to assess changes in both D and S delays under Biv pacing
Methods. 37 pts with DCM and wide QRS were studied by Tissue Doppler Imaging (TDI)
before and immediately after biV pacing. S and D parameters were measured using
delays between onset of QRS and onset of the TDI velocity curves. The septal and lateral
walls of the left ventricle were used to assess Intra DYS. Similar measurements between
lateral free walls of right and left ventricles were used to assess Inter DYS.
AMI IMI
Baseline
Mean ± Std 
6mo. Median 
Paired 
Difference, 
(95% C.I.)
Baseline
Mean ± Std
6mo. Median Paired 
Difference,
(95% C.I.)
LVEDV, cm3 297.6 ±97.4 
(n=48)
1.6 (-23.4, 20.7) 307.8±94.6 
(n=28)
-43.2 (-69.0, 0.4)†*
LVESV, cm3 229.6±89.5 
(n=48)
-5.4 (-18.6, 3.7) 235.1±82.3 
(n=28)
-24.1 (-66.6, -11.3)†*
LV EF, % 24.1±6.2 (n=48) 2.3 (0.8, 3.9)† 24.6±6.8 (n=28) 3.2 (0.2, 4.5)†
MR Jet 
Area, cm2
9.35±4.88 (n=36) -4.2 (-5.8, -2.6)† 8.20±5.32 (n=17) -4.0 (-5.9, 2.3)†
mean ± std MIRACLE
(n=196)
MIRACLE ICD
(n=165)
Baseline 6 mo Baseline 6 mo
LVEDV (ml) 302±107 266±109* 318±95 299±101*
LVESV (ml) 233±98 195±99* 245±88 224±94*
LVEF (%) 24.2±6.8 29.2±9.0* 24.2±6.5 27.3±8.9*
MR (cm2) 7.4±5.9 4.3±4.4* 7.7±6.0 6.4±5.4*
DT (ms) 199±84 236±108* 197±80 215±78*
pVO2 14.3±3.5 15.4±4.1* 13.5±3.5 14.3±3.7*
6’ HW (m) 310±83 335±125* 250±127 338±106*
QOL 59±20 39±24* 55±23 37±24*
Patient 
Subgroups
NYHA Class II NYHA Class III/
IV
RV Pacing QRS duration < 
150ms
Clinical 
Variables
Pre-
CRT
Post-
CRT
Pre-
CRT
Post-
CRT
Pre-
CRT
Post-
CRT
Pre-
CRT
Post-
CRT
NYHA Class 2 1.75 3.1* 2.5* 3.1* 2.5* 2.9* 2.5*
QRS Duration 
(ms)
171 159 174* 164* 195* 165* 137* 155*
LVEF (%) 17.9* 27.6* 18.9* 23* 18.1* 22.2* 22 22
LVEDD (cm) 6.6* 6.1* 6.8* 6.5* 6.4* 6.1* 6.6 6.5
LVESD (cm) 5.5* 4.8* 5.7* 5.3* 5.4* 5.1* 5.5 5.3
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Results. All delays significantly decreased under biV pacing (table).
Dyssynchrony was defined as a delay > 40 ms. Before Biv, 26 (74%) pts had both D and
S DYS, 1 (3%) had S DYS alone, and 6 (17%) had D DYS alone. Overall, S and D DYS
were observed in 27 (77%) and 32 (91%) pts, respectively at baseline, but only in 6
(19%) and 24 (69%) of pts under Biv. However, 4 new S and 7 new D DYS appeared after
BiV pacing.
Conclusion. Diastolic DYS is more frequent than systolic, and may be observed alone in
some pts. D DYS is less improved than S DYS by Biv pacing. Persistent D DYS may
explain some cases of lack of improvement after biV pacing despite good systolic resyn-
chronization.
9:45 a.m.
872-6 Atrial Pacing May Negate the Benefits of 
Resynchronization
Seth J. Worley, Douglas C. Gohn, Joann L. Tuzi, Lancaster Heart Foundation, Lancaster, 
PA, Lancaster General Heart Institute, Lancaster, PA
Background: Cardiac resynchronization therapy (CRT) was proven beneficial in the
VDD mode, however since FDA approval most patients are programmed DDD/DDDR
where single site right atrial pacing (SSRAP) dominates. The impact of SSRAP on the
delivery of CRT is not known and may have untoward effects similar to those of single
site RV pacing reported in the DAVID trial. The purpose of this study was to evaluate the
effect of SSRAP on atrial depolarization in patients receiving a CRT device.
Methods: At the time of implant 34 patients had bipolar electrograms recorded simulta-
neously from the RA pacing lead and a mid CS catheter during sinus rhythm and SSRAP.
The RA-LA activation time was measured from the onset of RA activation or pacer spike
to the end of LA activation in the mid CS.
Results: The mean sinus RA-LA activation time was 147.7ms compared to 204.1ms with
SSRAP. The paced RA-LA activation time was > 190ms in 55.9% and >200ms in 41.2%.
The difference between sinus and paced RA-LA activation time varied unpredictably from
-20 to 192ms.
Conclusion: SSRAP has a profound and unpredictable impact on the duration of atrial
depolarization, which has important implications for programming CRT devices. Although
paced RA-LA activation time is much longer than sinus, the sinus activation time does not
reliably predict the paced activation time. If nominal paced AV delay settings are used the
majority of pts will have LA contraction occur during LV contraction, producing pace-
maker syndrome. It may not be possible to program the paced AV delay to allow both
complete LA depolarization and LV pacing in cases where the RA-LA activation time
exceeds 190 ms. In these cases alternative approaches to atrial pacing for CRT are
needed.
ORAL CONTRIBUTIONS
876 Exercise Physiology and Risk Scores: 
Prognosis
Wednesday, March 10, 2004, 8:30 a.m.-10:00 a.m.
Morial Convention Center, Room 257
8:30 a.m.
876-1 The Duke Treadmill Score and Cardiac Mortality in 
Asymptomatic Women: The St James Women Take 
Heart Project
Martha Gulati, Dilip K. Pandey, Morton F. Arnsdorf, Diane S. Lauderdale, Roxanne H. 
Wicklund, Arfan J. Al-Hani, Henry R. Black, Rush University Medical Center, Chicago, IL
Background: Cardiovascular disease is the leading cause of death among women,
accounting for over half of their mortality. However, women have been underrepresented
in most studies of cardiovascular disease. Virtually no information is available concerning
the predictive value of exercise testing in asymptomatic women. The hypothesis that a
reduced Duke Treadmill Score (DTS) is associated with an increased risk of cardiac mor-
tality in women was investigated in a cohort of 5721 asymptomatic women who under-
went stress testing in 1992. Methods: A symptom-limited stress ECG using Bruce
Protocol was performed at baseline. The DTS was calculated as: Exercise time on the
Bruce Treadmill protocol in minutes-(5X maximal ST-depression)- (4XAngina Score
Index). The cohort was divided into 2 groups: low risk (DTS>5) or moderate-to-high risk
(DTS<5). A National Death Index Search was performed in 2001 to identify all deaths up
to the end of year 2000. Cardiac deaths were identified by ICD-9 codes 390-449 or ICD-
10 codes I00-I09,I11,I13,I20-I51,I60-I70, as appropriate. Survival analysis was per-
formed using Cox proportional-hazards regression models.
Results: The unadjusted risk of death decreased by 15% for each unit increment in the
DTS (p<0.001). After adjusting for the Framingham Risk Score (FRS), the risk of death
decreased by 9% for each unit increase in the DTS (p<0.001). Those in the lowest risk
DTS category had a 54% reduction in mortality compared to the moderate-to-high risk
DTS, after adjusting for the FRS (p<0.001). The risk of cardiovascular death decreased
by 13% for each unit increase in DTS, after adjusting for the FRS (P=0.003). Those with
the lowest risk DTS category had a 60% reduction in mortality compared to the moder-
ate-to-high risk DTS, after adjusting for the FRS (p<0.001).
Conclusion: This study has demonstrated that the DTS is an independent predictor of
mortality and cardiovascular mortality in asymptomatic women, even after adjusting for
traditional risk factors. The DTS is a valid tool for use in asymptomatic women.
8:45 a.m.
876-2 Global Risk Score and Exercise Testing for Predicting 
All-Cause Death in a Preventive Medicine Program
Mehmet K. Aktas, Volkan Ozduran, Claire E. Pothier, Michael S. Lauer, Cleveland Clinic 
Foundation, Cleveland, OH
Background: The usefulness of exercise testing in asymptomatic subjects is unclear.
Methods: We followed for a mean of 8 years 7309 asymptomatic adults (age 50+8, 84%
male) who underwent routine screening exercise testing as part of a preventive medicine
program.Global risk for death was assessed based on the European Systematic Coro-
nary Risk Evaluation (SCORE). Exercise test abnormalities included impaired physical
fitness, abnormal heart rate recovery, chronotropic incompetence, and ST-segment
abnormalities.
Results: There were 136 deaths. The 8-year predicted death risk based on the SCORE
was 1.81% while the actual death risk was 1.86%. In a multivariable model, independent
predictors of death were a higher SCORE (for 10% predicted increased risk, RR 1.13,
95% CI 1.11-1.15, P=0.0001), impaired functional capacity (RR 1.98, 95% CI 1.23-3.20,
P=0.005), and an abnormal heart rate recovery (RR 1.99, 95% 1.32-2.99, P=0.001). ST-
segment changes did not predict risk of death. There were 1173 (16%) subjects who had
either impaired fitness or an abnormal heart rate recovery. The Figure shows risk of
death according to tertile of SCORE and exercise test findings. In the highest tertile of
SCORE, an abnormal exercise test identified a risk of death close to 1% per year.
Conclusion: Exercise testing when combined with a global risk score may be useful for
stratifying risk in asymptomatic subjects in a preventive medicine program, particularly
when focusing on exercise capacity and heart rate recovery.
9:00 a.m.
876-3 The Prognostic Value of Percent Heart Rate Reserve, 
Heart Rate Recovery, and Exercise Capacity Over 
Myocardial Perfusion SPECT in the Prediction of 
Cardiac, Noncardiac, and All-Cause Mortality
Babak Azarbal, Sean W. Hayes, Rory Hachamovitch, John D. Friedman, Ishac Cohen, 
Daniel S. Berman, Cedars-Sinai Medical Center, Los Angeles, CA, University of 
California, Los Angeles, Los Angeles, CA
Background: While low percent heart rate reserve (%HR-Res), abnormal heart rate
recovery (HR-Rec), poor exercise capacity, and abnormal myocardial perfusion SPECT
(MPS) have separately been shown to be predictors of all-cause mortality and cardiac
death (CD), the relative contribution of these exercise variables to each end point has
never been examined together in a single population. 
Methods: 11,465 consecutive pts with no valvular disease and not on β-blockers under-
went symptom-limited exercise MPS; 815 pts were censored for early revascularization
(<60 days). %HR-Res = [(peak HR - rest HR)/(220-age-rest HR)] x100, with %HR-Res
<80% defined as low. HR-Rec = [peak HR - recovery HR]. HR-Rec < 22 bpm at 2 min
post peak exercise was considered abnormal. Exercise capacity < 7 MET was consid-
ered poor. Summed stress perfusion scores (SSS) were calculated using a 20-segment
model, 5-point scoring scale, as previously described. Analysis was performed using sur-
vival modeling.
Results: Of 10,216 pts, there were 339 deaths (133 CD/209 noncardiac deaths (NCD)).
Mean follow-up was 789 + 412 days (96% complete). The predictors of all-cause mortal-
ity, CD, and NCD from multivariable analysis are shown in the table.
Conclusion: Exercise capacity, %HR-Res, and HR-Rec are exercise variables which
QRS width S Inter S Intra D Inter D Intra
basal 166 ±24 55 ±35 44 ±31 51 ±44 42 ±42
biV pacing 113 ±20 6 ±13 16 ±29 34 ±32 32 ±43
p < .0001 < .0001 0.003 0,04 ns
